LCLuisa Lemos Costa

Luisa Lemos Costa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luisa Lemos Costa has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immunosuppression with Rituximab in Glomerular Diseases in Adults: Who, How and When?

    by Raquel Pinto, Centro Hospitalar Tondela-Viseu Serviço de Nefrologia, Carolina Ferreira, André Ferreira, Joaquim Milheiro, Catarina Veiga, Maria Costa, Andreia Silva, Carla Lima, Sérgio Lemos, et al.

  • Open Access

    Biologically Unrelated Living Donor for Kidney Transplantation Associated With Higher Acute Rejection Rate but With Similar Graft Survival of a Related Living Donor

    by Pedro Reis Pereira, Manuela Almeida, Bárbara Ribeiro, João Oliveira, Luisa Costa, Sofia Pedroso, La Salete Martins, Leonídio Dias, Jorge Malheiro

    Introduction: Kidney transplantation (KT) from living donors has been shown to have multiple benefits compared to those from deceased donors. We sought to compare significant graft outcomes, namely acute rejection (AR), graft function, and survival between transplant recipients who received a kidney from living related donor (LRD) and living unrelated donor (LURD). Methods: Our cohort comprised 198 donor and recipient pairs undergoing living-donor KT at our center over 10 years. The LRD recipients were compared with LURD recipients according to demographic and clinical characteristics, transplant variables (including immunosuppression), graft function, survival, and AR rate. Results: The estimated glomerular filtration rate (eGFR) was similar in both groups over the follow-up time i.e., 60-65 mL/min (p>0.05 over 10 years). Censored graft survival was similar between LRD and LURD recipients (96.9% vs. 98.0% at five years and 87.8% vs. 79.4% at 10 years, respectively; p=0.837). The LURD recipients had a higher incidence of AR, although LURD recipient status was not an independent risk factor for AR. Multivariate analysis showed that human leukocyte antigen (HLA)-DR mismatch (MM) was an independent predictor of AR (hazard ratio (HR) 2.256, p<0.05). Both HLA-A and HLA-B MM did not affect the AR HR between the groups. Conclusion: Graft function and censored graft survival rates were similar between LURD and LRD KT recipients in our study. The AR was higher in LURD recipients, although the LURD recipient status was not an independent risk factor for AR. The HLA-DR MM was an independent predictor of AR, while HLA-A and HLA-B MM did not affect AR HR between groups of patients.


  • Open Access

    Case report: rivaroxaban related nephropathy

    by Luisa Lemos Costa, Ana Rodrigues, Raquel Pinto, Carla Lima, Tânia Sousa, Helena Viana, Mário Góis, Sérgio Lemos, Andreia Silva

    The characteristics of direct oral anticoagulants (DOACs) make them more appealing for prevention of thromboembolic events than vitamin K antagonists (VKA). Despite that, both classes have been a recognized as a cause of anticoagulant related nephropathy (ARN). Herein we describe a case of a 72-year-old man, with chronic kidney disease (CKD), medicated with rivaroxaban, who presented with acute kidney injury (AKI) and microscopic hematuria. The kidney biopsy revealed anticoagulant related-nephropathy. Rivaroxaban was suspended, the patient showed improvement of renal function and apixaban was prescribed. This case emphasizes the need for careful monitoring of serum creatinine when these drugs are prescribed, especially in high risk groups.


  • Open Access

    Membranous nephropathy with collapse in a HIV negative patient; a case report with a 34-month follow-up

    by Luisa Lemos Costa, Ana Isabel Rodrigues, Carolina Ferreira, Carla Pereira Lima, Tânia Couto Sousa, Helena Viana, Mário Góis, Sérgio Silva Lemos

    Membranous nephropathy (MN) is a common cause of nephrotic syndrome (NS) in nondiabetic adults. Collapsing nephropathy (CN) is a morphological pattern that is usually classified as a variant of focal segmental glomerulosclerosis (cFSGS). The simultaneous presence of both MN and CN is rare and their combination usually foresees an unfavorable outcome. Herein, we describe a case report of a patient with PLA2 R-associated MN with collapse, its treatment and clinical course.